These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29430546)

  • 41. Low conversion rate of ocular to generalized myasthenia gravis in Singapore.
    Teo KY; Tow SL; Haaland B; Gosavi TD; Jing-Liang L; Yew Long LO; Milea D
    Muscle Nerve; 2018 May; 57(5):756-760. PubMed ID: 28981152
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
    Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
    Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy for ocular myasthenia gravis: an observational study in Japan.
    Narita T; Nakane S; Nagaishi A; Minami N; Niino M; Kawaguchi N; Murai H; Kira JI; Shimizu J; Iwasa K; Yoshikawa H; Hatanaka Y; Sonoo M; Shimizu Y; Matsuo H
    Ther Adv Neurol Disord; 2023; 16():17562864231163819. PubMed ID: 37051222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study.
    Guo RJ; Gao T; Ruan Z; Zhou HY; Gao F; Xu Q; Yu LP; Wu SD; Lei T; Li HH; Sun C; Zhang M; Gao YW; Lu XD; Tang YL; Tang BL; Huo FY; Zhu Y; Li ZY; Chang T
    Neurol Ther; 2022 Mar; 11(1):73-86. PubMed ID: 34729706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202 patients.
    Hong YH; Kwon SB; Kim BJ; Kim BJ; Kim SH; Kim JK; Park KS; Park KJ; Sung JJ; Sohn EH; Lee YB; Jeong D; Joo IS; Choi BO; Choi YC;
    J Neurol Sci; 2008 Oct; 273(1-2):10-4. PubMed ID: 18602121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymic TFH cells involved in the pathogenesis of myasthenia gravis with thymoma.
    Zhang M; Zhou Y; Guo J; Li H; Tian F; Gong L; Wang X; Lan M; Li Z; Zhang W
    Exp Neurol; 2014 Apr; 254():200-5. PubMed ID: 24518487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies in Japanese patients with ocular myasthenia gravis.
    Nagaishi A; Narita T; Woodhall M; Jacobson L; Waters P; Irani SR; Vincent A; Matsuo H
    Muscle Nerve; 2021 Feb; 63(2):262-267. PubMed ID: 33094484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
    Kupersmith MJ
    J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prediction of generalization of ocular myasthenia gravis under immunosuppressive therapy in Northwest China.
    Ding J; Zhao S; Ren K; Dang D; Li H; Wu F; Zhang M; Li Z; Guo J
    BMC Neurol; 2020 Jun; 20(1):238. PubMed ID: 32527235
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential Gut Microbiota and Fecal Metabolites Related With the Clinical Subtypes of Myasthenia Gravis.
    Tan X; Huang Y; Chai T; Zhao X; Li Y; Wu J; Zhang H; Duan J; Liang W; Yin B; Cheng K; Yu G; Zheng P; Xie P
    Front Microbiol; 2020; 11():564579. PubMed ID: 33013794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic nomogram for predicting generalized conversion in adult-onset ocular myasthenia gravis.
    Bi Z; Cao Y; Gui M; Lin J; Zhang Q; Li Y; Ji S; Bu B
    Neurol Sci; 2023 Apr; 44(4):1383-1391. PubMed ID: 36469201
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accuracy of Repetitive Ocular Vestibular-Evoked Myogenic Potentials to Diagnose Myasthenia Gravis in Patients With Ptosis or Diplopia.
    Valko Y; Wirth MA; Fierz FC; Schesny MK; Rosengren S; Schmückle-Meier T; Bockisch CJ; Straumann D; Schreiner B; Weber KP
    Neurology; 2024 May; 102(10):e209395. PubMed ID: 38669629
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Acupuncture combined with western medication for ocular myasthenia gravis: a randomized controlled trial].
    Xu XP; Jiang YB; Guan LH; Ji QJ; Jin Y
    Zhongguo Zhen Jiu; 2022 Jul; 42(7):755-9. PubMed ID: 35793884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular myasthenia gravis saccades as a measure of extraocular muscle function.
    Wong SH; Bancroft MJ; Tailor VK; Abbas M; Sekar A; Noble C; Theodorou M; Kaski D
    Front Ophthalmol (Lausanne); 2022; 2():938088. PubMed ID: 38983530
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictive value of single-fiber electromyography in the extensor digitorum communis muscle of patients with ocular myasthenia gravis: a retrospective study.
    Rostedt A; Saders LL; Edards LJ; Massey JM; Sanders DB; Stålberg EV
    J Clin Neuromuscul Dis; 2000 Sep; 2(1):6-9. PubMed ID: 19078595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalences of Other Non-Thyroid Autoimmune Diseases and Factor Associated with Their Presence in Ocular Myasthenia Gravis.
    Anutraungkool T; Padungkiatsagul T; Jindahra P; Vanikieti K
    Clin Ophthalmol; 2024; 18():1125-1132. PubMed ID: 38686013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular myasthenia gravis - How effective is low dose prednisone long term?
    Verma R; Wolfe GI; Kupersmith MJ
    J Neurol Sci; 2021 Jan; 420():117274. PubMed ID: 33360170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors for conversion to generalization in ocular myasthenia gravis.
    Witthayaweerasak J; Rattanalert N; Aui-Aree N
    Medicine (Baltimore); 2021 May; 100(19):e25899. PubMed ID: 34106649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical differences of early and late-onset myasthenia gravis in 985 patients.
    Fan L; Ma S; Yang Y; Yan Z; Li J; Li Z
    Neurol Res; 2019 Jan; 41(1):45-51. PubMed ID: 30311866
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.